Lorastad D Syrup

Lorastad D Syrup containing desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity, are indicated for the relief of symptoms associated with allergic rhinitis and urticaria.

Pack size Box of 10 ampoules x 5ml. Box of 01 bottle x 60 ml
Shelf-life 24 months
Composition Desloratadine
Dosage forms and strengths 5 ml syrup: 2.5 mg
60 ml syrup: 30 mg
Product code :



The relief of symptoms associated with allergic rhinitis and urticaria.


  • Adults and adolescents (12 years of age and over): The recommended dose is 10 ml once daily.
  • Children 1 – 5 years of age: 2.5 ml once daily.
  • Children 6 – 11 years of age: 5 ml once daily.
  • The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin and there are no data supporting the treatment of infectious rhinitis with desloratadine.
  • Safety and efficacy of Lorastad D Syrup in children below the age of 1 year have not been established.
  • There is limited clinical trial efficacy experience with the use of desloratadine in children 1 through 11 years of age and adolescents 12 through 17 years of age.


Lorastad D Syrup is orally administered, regardless to meals.

Known hypersensitivity to desloratadine, loratadine, or to any of the ingredients.


  • Fatigue, dry mouth and headache.


  • Hallucinations, dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures; tachycardia, palpitations;
  • Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea;
  • Elevations of liver enzymes, increased bilirubin, hepatitis;
  • Myalgia;
  • Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnea, pruritus, rash, and urticaria).
  • The safety and efficacy of Lorastad D Syrup in children below the age of 12 years have not been established.
  • In the case of severe renal insufficiency, desloratadine should be used with caution.
  • Desloratadine should be administered with caution in patients with medical or familial history of seizures, patients with severe renal impairment.
  • The use of Lorastad D Syrup during pregnancy in breastfeeding women is not recommended.
  • Lorastad D Syrup contains sorbitol. Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.
  • Lorastad D Syrup contains sucrose (saccharose). Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine.
  • Lorastad D Syrup contains coloring agent (sunset yellow) which may cause allergic reactions.
  • Patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. Patients should be aware of how they react to drug before driving or operating machinery.